Total trials
60
Active
8
Phase 3
3
Total enrollment
243,293
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Methadone | — | — | — | — | — | 1 | |
| ketamine | — | — | — | — | — | 1 | |
| Hydromorphone | — | — | — | — | — | 1 | |
| fentanyl | — | — | — | — | — | 1 | |
| Long-Acting Local Anesthesia | — | — | — | — | — | 1 | |
| Regional Anesthesia | — | — | — | — | — | 1 |
Next readouts
- 2026-07-01
- 2026-09-01
Top conditions
- Hepatocellular Carcinoma3
- Sinusitis2
- Pain2
- Interstitial Lung Disease2
- Cervical Spondylosis With Myelopathy2
- Bladder Neoplasms2
- Progressive Supranuclear Palsy2
- Chronic Sinusitis2
Frequently asked questions about Lahey Clinic
- How many clinical trials does Lahey Clinic have on ClinicalTrials.gov?
- Lahey Clinic is listed as the lead sponsor on 60 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Lahey Clinic's trials are in Phase 3?
- 3 of Lahey Clinic's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Lahey Clinic focus on?
- Lahey Clinic's most-studied conditions on ClinicalTrials.gov are Hepatocellular Carcinoma, Sinusitis, Pain, Interstitial Lung Disease, Cervical Spondylosis With Myelopathy.
- When are Lahey Clinic's next clinical trial readouts?
- Lahey Clinic has 2 upcoming primary-completion readouts tracked here; the soonest is “Reducing Pain With Methadone and Ketamine in Liver Transplant”, expected around 2026-07-01.